Nextage Therapeutics (Israel) Buy Hold or Sell Recommendation

MCTC Stock  ILA 37.70  1.30  3.33%   
Assuming the 90 days trading horizon and your highly speculative risk level, our recommendation regarding Nextage Therapeutics is 'Strong Sell'. Macroaxis provides Nextage Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MCTC positions. The advice algorithm takes into account all of Nextage Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Osisko Gold Ro's buy or sell advice are summarized below:
Real Value
31.42
Hype Value
37.7
Market Value
37.7
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Nextage Therapeutics given historical horizon and risk tolerance towards Nextage Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Nextage Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Nextage Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Nextage and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute Nextage Therapeutics Buy or Sell Advice

The Nextage recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nextage Therapeutics. Macroaxis does not own or have any residual interests in Nextage Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nextage Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nextage TherapeuticsBuy Nextage Therapeutics
Strong Sell

Market Performance

ModestDetails

Volatility

Not too volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Moves completely opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Nextage Therapeutics has a Mean Deviation of 3.35, Semi Deviation of 3.43, Standard Deviation of 5.37, Variance of 28.79, Downside Variance of 15.32 and Semi Variance of 11.75
Nextage Therapeutics trade recommendations module can be used to check and cross-verify current advice provided by analysts analyzing the firm's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Nextage Therapeutics is not overpriced, please verify all Nextage Therapeutics fundamentals, including its ebitda, cash and equivalents, debt to equity, as well as the relationship between the net income and cash per share .

Nextage Therapeutics Trading Alerts and Improvement Suggestions

Nextage Therapeutics had very high historical volatility over the last 90 days
Nextage Therapeutics has a very high chance of going through financial distress in the upcoming years
The company has 0.0 in debt which may indicate that it relies heavily on debt financing
The company has a current ratio of 0.43, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nextage Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Nextage Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nextage Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nextage to invest in growth at high rates of return. When we think about Nextage Therapeutics' use of debt, we should always consider it together with cash and equity.
Nextage Therapeutics reported the revenue of 297 K. Net Loss for the year was (2.09 M) with profit before overhead, payroll, taxes, and interest of 207 K.
Nextage Therapeutics has accumulated about 358 K in cash with (5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Roughly 22.0% of the company outstanding shares are owned by corporate insiders

Nextage Therapeutics Returns Distribution Density

The distribution of Nextage Therapeutics' historical returns is an attempt to chart the uncertainty of Nextage Therapeutics' future price movements. The chart of the probability distribution of Nextage Therapeutics stock daily returns describes the distribution of returns around its average expected value. We use Nextage Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nextage Therapeutics returns is essential to provide solid investment advice for Nextage Therapeutics.
Mean Return
0.42
Value At Risk
-4.98
Potential Upside
8.60
Standard Deviation
5.37
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nextage Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nextage Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nextage Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nextage Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nextage stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.74
β
Beta against NYSE Composite-2.46
σ
Overall volatility
5.74
Ir
Information ratio 0.05

Nextage Therapeutics Volatility Alert

Nextage Therapeutics shows above-average downside volatility for the selected time horizon. We advise investors to inspect Nextage Therapeutics further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Nextage Therapeutics future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nextage Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nextage Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Nextage Therapeutics Fundamentals Vs Peers

Comparing Nextage Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nextage Therapeutics' direct or indirect competition across all of the common fundamentals between Nextage Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nextage Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nextage Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Nextage Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Nextage Therapeutics to competition
FundamentalsNextage TherapeuticsPeer Average
Return On Asset-0.37-0.14
Profit Margin(2.30) %(1.27) %
Operating Margin(9.71) %(5.51) %
Shares Outstanding2.27 M571.82 M
Shares Owned By Insiders22.39 %10.09 %
Shares Owned By Institutions0.02 %39.21 %
Price To Earning(91.98) X28.72 X
Price To Book4.68 X9.51 X
Price To Sales26.11 X11.42 X
Revenue297 K9.43 B
Gross Profit207 K27.38 B
EBITDA(5.38 M)3.9 B
Net Income(2.09 M)570.98 M
Cash And Equivalents358 K2.7 B
Cash Per Share0.16 X5.01 X
Debt To Equity65.70 %48.70 %
Current Ratio0.44 X2.16 X
Book Value Per Share0.90 X1.93 K
Cash Flow From Operations(5 M)971.22 M
Earnings Per Share(0.24) X3.12 X
Number Of Employees618.84 K
Beta1.05-0.15
Market Capitalization9.54 M19.03 B
Total Asset6.01 M29.47 B
Retained Earnings(103 M)9.33 B
Working Capital1000 K1.48 B
Current Asset3 M9.34 B
Current Liabilities2 M7.9 B
Z Score-23.88.72
Net Asset6.01 M

Nextage Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nextage . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Nextage Therapeutics Buy or Sell Advice

When is the right time to buy or sell Nextage Therapeutics? Buying financial instruments such as Nextage Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Nextage Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Check out Nextage Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.